Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
OrthoArkansas, P. A.
mi
from
Little Rock, AR
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
OrthoArkansas, P. A.
mi
from
Little Rock, AR
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Orthoarkansas
mi
from
Little Rock, AR
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Orthoarkansas
mi
from
Little Rock, AR
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Patricia Fodor
mi
from
Colorado Springs, CO
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Patricia Fodor
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Sunrise Clinical Research, Inc.
mi
from
Hollywood, FL
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Sunrise Clinical Research, Inc.
mi
from
Hollywood, FL
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Meridien Research
mi
from
Tampa, FL
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Meridien Research
mi
from
Tampa, FL
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
MS Center of Atlanta
mi
from
Atlanta, GA
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
MS Center of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
OSF Saint Francis Medical Center
mi
from
Peoria, IL
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Elkhardt Clinic
mi
from
Elkhart, IN
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Elkhardt Clinic
mi
from
Elkhart, IN
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
MidAmerica Neuroscience Institute
mi
from
Lenexa, KA
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
MidAmerica Neuroscience Institute
mi
from
Lenexa, KA
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Springfield Neurology
mi
from
Springfield, MA
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Springfield Neurology
mi
from
Springfield, MA
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
General Clinical Research Center 7A
mi
from
Ann Arbor, MI
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
General Clinical Research Center 7A
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Medex Healthcare Research, Inc.
mi
from
St. Louis, MI
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Medex Healthcare Research, Inc.
mi
from
St. Louis, MI
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Northern Michigan Neurology
mi
from
Traverse City, MI
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Northern Michigan Neurology
mi
from
Traverse City, MI
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Winthrop University Hospital
mi
from
Mineola, NY
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Crozer-Chester Medical Center
mi
from
Upland, PA
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Crozer-Chester Medical Center
mi
from
Upland, PA
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Bhupesh Dihenia, M.D., P.A.
mi
from
Lubbock, TX
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Bhupesh Dihenia, M.D., P.A.
mi
from
Lubbock, TX
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Integra Clinical Research
mi
from
San Antonio, TX
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Integra Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
The Neurological Research center, Inc
mi
from
Bennington, VT
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
The Neurological Research center, Inc
mi
from
Bennington, VT
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
VCU Medical Center
mi
from
Richmond, VA
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Montreal Neurological Institute and Hospital
mi
from
Montreal,
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Montreal Neurological Institute and Hospital
mi
from
Montreal,
Click here to add this to my saved trials
Evaluating Human-Machine Interfaces in a Robotic Thumb Orthosis
Development and Evaluation of a Human-Machine Interface for Grasp Assistance Using a Robotic Thumb Orthosis in Children With Hemiplegic Cerebral Palsy and Hemiplegic Stroke
Status: Enrolling
Updated:  9/9/2015
Children's Hospital Boston
mi
from
Boston, MA
Evaluating Human-Machine Interfaces in a Robotic Thumb Orthosis
Development and Evaluation of a Human-Machine Interface for Grasp Assistance Using a Robotic Thumb Orthosis in Children With Hemiplegic Cerebral Palsy and Hemiplegic Stroke
Status: Enrolling
Updated: 9/9/2015
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Folate Rechallenge
Folate Rechallenge: A Pilot Study
Status: Enrolling
Updated:  9/10/2015
Baylor College of Medicine
mi
from
Houston, TX
Folate Rechallenge
Folate Rechallenge: A Pilot Study
Status: Enrolling
Updated: 9/10/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated:  9/10/2015
Merz Investigational Site # 001235
mi
from
Indianapolis, IN
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated: 9/10/2015
Merz Investigational Site # 001235
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated:  9/10/2015
Merz Investigative Site #001232
mi
from
Cleveland, OH
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated: 9/10/2015
Merz Investigative Site #001232
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated:  9/10/2015
Merz Investigational Site #001237
mi
from
Milwaukee, WI
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated: 9/10/2015
Merz Investigational Site #001237
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated:  9/10/2015
Merz Investigational Site # 001197
mi
from
Doral, FL
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated: 9/10/2015
Merz Investigational Site # 001197
mi
from
Doral, FL
Click here to add this to my saved trials
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated:  9/10/2015
Merz Investigative Site #001233
mi
from
New York, NY
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated: 9/10/2015
Merz Investigative Site #001233
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated:  9/10/2015
Merz Investigative Site# 01252
mi
from
Charlotte, NC
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated: 9/10/2015
Merz Investigative Site# 01252
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated:  9/10/2015
Merz Investigational Site # 001203
mi
from
Calgary, AB,
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Prospective, Open-label, Non-randomized, Single-arm, Multi-center Dose Titration Study to Investigate the Safety and Efficacy of NT 201 in Subjects Deemed to Require Total Body Doses of 800 U of NT 201 During the Course of the Study for the Treatment of Upper and Lower Limb Spasticity of the Same Body Side Due to Cerebral Causes
Status: Enrolling
Updated: 9/10/2015
Merz Investigational Site # 001203
mi
from
Calgary, AB,
Click here to add this to my saved trials
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated:  9/10/2015
UCLA, Neuromuscular Research Center
mi
from
Los Angeles, CA
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated: 9/10/2015
UCLA, Neuromuscular Research Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated:  9/10/2015
University of Iowa
mi
from
Iowa City, IA
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated: 9/10/2015
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated:  9/10/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated: 9/10/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated:  9/10/2015
Massachusetts General Hospital
mi
from
Boston, MA
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated: 9/10/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated:  9/10/2015
Washington University Medical School
mi
from
Saint Louis, MO
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated: 9/10/2015
Washington University Medical School
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated:  9/10/2015
SUNY Upstate Medical Center
mi
from
Syracuse, NY
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated: 9/10/2015
SUNY Upstate Medical Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated:  9/10/2015
UT Southwestern Medical Center
mi
from
Dallas, TX
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated: 9/10/2015
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated:  9/10/2015
University of Washington Medical Center
mi
from
Seattle, WA
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated: 9/10/2015
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated:  9/10/2015
University of Massachusetts (Worcester) Memorial Medical Center
mi
from
Worcester, MA
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated: 9/10/2015
University of Massachusetts (Worcester) Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated:  9/10/2015
Penn State Hershey Medical Center
mi
from
Hershey, PA
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Status: Enrolling
Updated: 9/10/2015
Penn State Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients
Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients
Status: Enrolling
Updated:  9/11/2015
University of Tennessee Medical Center
mi
from
Knoxville, TN
Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients
Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients
Status: Enrolling
Updated: 9/11/2015
University of Tennessee Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Robotic Brace Incorporating Electromyography for Moderate Affected Arm Impairment After Stroke
Robotic Brace Incorporating EMG for Moderate Affected Arm Impairment After Stroke
Status: Enrolling
Updated:  9/15/2015
Ohio State University
mi
from
Columbus, OH
Robotic Brace Incorporating Electromyography for Moderate Affected Arm Impairment After Stroke
Robotic Brace Incorporating EMG for Moderate Affected Arm Impairment After Stroke
Status: Enrolling
Updated: 9/15/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Pilot Study of an RCT to Improve Infection Management in Advanced Dementia
A Pilot Study of an RCT to Improve Infection Management in Advanced Dementia
Status: Enrolling
Updated:  9/15/2015
Hebrew SeniorLife
mi
from
Boston, MA
A Pilot Study of an RCT to Improve Infection Management in Advanced Dementia
A Pilot Study of an RCT to Improve Infection Management in Advanced Dementia
Status: Enrolling
Updated: 9/15/2015
Hebrew SeniorLife
mi
from
Boston, MA
Click here to add this to my saved trials
Stroke and CPAP Outcome Study: A Sham-controlled Trial of CPAP Among Stroke Rehabilitation Patients
Randomized Trial of Continuous Positive Airway Pressure in Patients Undergoing Intensive Inpatient Rehabilitation After Acute Stroke
Status: Enrolling
Updated:  9/15/2015
Univ of Washington
mi
from
Seattle, WA
Stroke and CPAP Outcome Study: A Sham-controlled Trial of CPAP Among Stroke Rehabilitation Patients
Randomized Trial of Continuous Positive Airway Pressure in Patients Undergoing Intensive Inpatient Rehabilitation After Acute Stroke
Status: Enrolling
Updated: 9/15/2015
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Engaging Caregivers in Dementia Care
Engaging Caregivers in the Care of Veterans With Dementia
Status: Enrolling
Updated:  9/15/2015
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Engaging Caregivers in Dementia Care
Engaging Caregivers in the Care of Veterans With Dementia
Status: Enrolling
Updated: 9/15/2015
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Intranasal Oxytocin and Learning in Autism
Promoting Social Perceptual Learning With Oxytocin in Autism
Status: Enrolling
Updated:  9/16/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Intranasal Oxytocin and Learning in Autism
Promoting Social Perceptual Learning With Oxytocin in Autism
Status: Enrolling
Updated: 9/16/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, Illinois
mi
from
Chicago, IL
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, North Carolina
mi
from
Charlotte, NC
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, North Carolina
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, Texas
mi
from
Austin, TX
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, Texas
mi
from
Houston, TX
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, Texas
mi
from
Houston, TX
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, Texas
mi
from
Houston, TX
Click here to add this to my saved trials